Sign inGet started

Fair Brett

Insider CIK 1737277 · ACRS Chief Commercial Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ACRS Aclaris Therapeutics, Inc. M Exercise deriv2019-02-012019-02-053,875— $011,625SEC↗
ACRS Aclaris Therapeutics, Inc. F Tax w/h2019-02-012019-02-051,308$6.96 $9.1K10,582SEC↗
ACRS Aclaris Therapeutics, Inc. M Exercise2019-02-012019-02-053,875— $011,890SEC↗
ACRS Aclaris Therapeutics, Inc. M Exercise deriv2018-12-182018-12-211,750— $01,750SEC↗
ACRS Aclaris Therapeutics, Inc. F Tax w/h2018-12-182018-12-21498$6.30 $3.1K8,015SEC↗
ACRS Aclaris Therapeutics, Inc. M Exercise2018-12-182018-12-211,750— $08,513SEC↗
ACRS Aclaris Therapeutics, Inc. M Exercise deriv2018-12-152018-12-181,013— $02,025SEC↗
ACRS Aclaris Therapeutics, Inc. M Exercise2018-12-152018-12-181,013— $07,051SEC↗
ACRS Aclaris Therapeutics, Inc. F Tax w/h2018-12-152018-12-18288$7.31 $2.1K6,763SEC↗
ACRS Aclaris Therapeutics, Inc. M Exercise deriv2018-05-072018-05-094,050— $03,038SEC↗
ACRS Aclaris Therapeutics, Inc. M Exercise2018-05-072018-05-094,050— $07,191SEC↗
ACRS Aclaris Therapeutics, Inc. F Tax w/h2018-05-072018-05-091,153$18.10 $20.9K6,038SEC↗